Log in

NYSE:GMREGlobal Medical REIT Stock Price, Forecast & News

-0.53 (-4.71 %)
(As of 05/29/2020 04:00 PM ET)
Today's Range
Now: $10.72
50-Day Range
MA: $10.62
52-Week Range
Now: $10.72
Volume300,189 shs
Average Volume498,857 shs
Market Capitalization$482.51 million
P/E Ratio97.46
Dividend Yield7.11%
Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.
Read More
Global Medical REIT logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 4.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.48 out of 5 stars

Industry, Sector and Symbol

Industry Real estate investment trusts



Sales & Book Value

Annual Sales$70.73 million
Cash Flow$0.78 per share
Book Value$8.08 per share


Net Income$9.23 million


Market Cap$482.51 million
Next Earnings Date8/5/2020 (Estimated)

Receive GMRE News and Ratings via Email

Sign-up to receive the latest news and ratings for GMRE and its competitors with MarketBeat's FREE daily newsletter.

Global Medical REIT (NYSE:GMRE) Frequently Asked Questions

How has Global Medical REIT's stock been impacted by COVID-19 (Coronavirus)?

Global Medical REIT's stock was trading at $12.41 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, GMRE stock has decreased by 13.6% and is now trading at $10.72. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Global Medical REIT?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 5 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Global Medical REIT.

When is Global Medical REIT's next earnings date?

Global Medical REIT is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for Global Medical REIT.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc (NYSE:GMRE) announced its quarterly earnings data on Wednesday, May, 6th. The company reported $0.03 earnings per share for the quarter, missing the consensus estimate of $0.20 by $0.17. The business earned $21.65 million during the quarter, compared to the consensus estimate of $21.04 million. Global Medical REIT had a return on equity of 2.58% and a net margin of 11.13%. View Global Medical REIT's earnings history.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT announced a quarterly dividend on Tuesday, March 3rd. Stockholders of record on Wednesday, March 25th will be given a dividend of $0.20 per share on Thursday, April 9th. This represents a $0.80 annualized dividend and a dividend yield of 7.46%. The ex-dividend date of this dividend is Tuesday, March 24th. View Global Medical REIT's dividend history.

What price target have analysts set for GMRE?

5 analysts have issued twelve-month target prices for Global Medical REIT's shares. Their forecasts range from $12.00 to $17.00. On average, they anticipate Global Medical REIT's share price to reach $15.10 in the next twelve months. This suggests a possible upside of 40.9% from the stock's current price. View analysts' price targets for Global Medical REIT.

Has Global Medical REIT been receiving favorable news coverage?

Media stories about GMRE stock have trended very negative this week, according to InfoTrie. The research group identifies negative and positive news coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Global Medical REIT earned a daily sentiment score of -3.0 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 3.0 out of 10, indicating that recent news coverage is unlikely to have an impact on the company's share price in the next few days. View the latest news aboutGlobal Medical REIT.

Who are some of Global Medical REIT's key competitors?

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), Insys Therapeutics (INSY), General Electric (GE), Square (SQ), Big Lots (BIG), New Residential Investment (NRZ), Ready Capital (RC), AGNC Investment (AGNC), AT&T (T) and Energy Transfer LP Unit (ET).

Who are Global Medical REIT's key executives?

Global Medical REIT's management team includes the following people:
  • Jeffrey Mark Busch, Chairman, President & Chief Executive Officer
  • Danica Holley, Chief Operating Officer
  • Robert J. Kiernan, Chief Financial Officer & Treasurer
  • Alfonzo Leon, Chief Investment Officer
  • Allen E. Webb, Senior VP-SEC Reporting & Technical Accounting

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an IPO on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different retail and institutional investors. Top institutional investors include BlackRock Inc. (6.72%), State Street Corp (2.09%), Wells Fargo & Company MN (1.91%), Geode Capital Management LLC (1.29%), Invesco Ltd. (1.18%) and JPMorgan Chase & Co. (0.89%). Company insiders that own Global Medical REIT stock include Henry Cole, Ronald Marston, Roscoe M Moore Jr and Zh Usa, Llc. View institutional ownership trends for Global Medical REIT.

Which institutional investors are selling Global Medical REIT stock?

GMRE stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Two Sigma Investments LP, Foundry Partners LLC, Nuveen Asset Management LLC, ClariVest Asset Management LLC, UBS Group AG, Chicago Equity Partners LLC, and WINTON GROUP Ltd. View insider buying and selling activity for Global Medical REIT.

Which institutional investors are buying Global Medical REIT stock?

GMRE stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., State Street Corp, Crown Advisors Management Inc., JPMorgan Chase & Co., Virtus ETF Advisers LLC, Geode Capital Management LLC, Wells Fargo & Company MN, and Wedge Capital Management L L P NC. Company insiders that have bought Global Medical REIT stock in the last two years include Henry Cole, Ronald Marston, and Zh Usa, Llc. View insider buying and selling activity for Global Medical REIT.

How do I buy shares of Global Medical REIT?

Shares of GMRE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $10.72.

How big of a company is Global Medical REIT?

Global Medical REIT has a market capitalization of $482.51 million and generates $70.73 million in revenue each year. The company earns $9.23 million in net income (profit) each year or $0.75 on an earnings per share basis.

What is Global Medical REIT's official website?

The official website for Global Medical REIT is www.globalmedicalreit.com.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The company can be reached via phone at 202-524-6851.

This page was last updated on 5/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.